U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07197749) titled 'Vitamin C With Steroids for Gastrointestinal GVHD' on Sept. 26.
Brief Summary: After a transplant from another donor, one risk is graft versus host disease (GVHD) that happens because of differences between the donated cells (graft) and the patient's body cells (host). The new cells from the donor might see the body's cells as different and attack them. GVHD can be very serious and cause death. The standard first treatment for GVHD is corticosteroids but not all patients respond and in cases where they don't, they need to go onto other treatments that may or may not be effective. In addition, when GHVD involves the gut it can damag...